In one paragraphArticle in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 14 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
35 authors at 6 institutions in 2 countries.
Jeanette A I JohnsonDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0002-8268-5335 Genevieve L Stein-O'BrienDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0001-8681-9110 Max BoothDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0009-0003-4707-5640 Randy HeilandDepartment of Intelligent Systems Engineering, Indiana University. Bloomington, IN USA.ORCID 0000-0002-7440-2905 Furkan KurtogluDepartment of Intelligent Systems Engineering, Indiana University. Bloomington, IN USA.ORCID 0000-0003-4547-1220 Daniel R BergmanDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0002-2166-6616 Atul DeshpandeDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0001-5144-6924 André ForjazDepartment of Chemical and Biomolecular Engineering, Johns Hopkins University. Baltimore, MD USA.
Melissa LymanDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0002-0091-0413 Andrew RaddatzDepartment of Biomedical Engineering, Georgia Institute of Technology, Emory University. Atlanta, GA USA.ORCID 0000-0001-6096-0968 Aneequa SundusDepartment of Intelligent Systems Engineering, Indiana University. Bloomington, IN USA.ORCID 0000-0001-6833-2341 Danielle GilkesDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0003-3984-9338 Luciane T KagoharaDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0003-1706-0950 Ashley L KiemenDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.
Elizabeth D ThompsonDepartment of Pathology, Johns Hopkins University. Baltimore, MD USA.
Denis WirtzDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0001-6147-3045 Pei-Hsun WuConvergence Institute, Johns Hopkins University. Baltimore, MD USA.
Neeha ZaidiDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0002-0094-0049 Lei ZhengDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.
Jacquelyn W ZimmermanDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0002-7775-2943 Elizabeth M JaffeeDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0003-3841-6549 Young Hwan ChangDepartment of Biomedical Engineering, Oregon Health & Science University. Portland, OR USA.ORCID 0000-0001-8764-1959 Lisa M CoussensDepartment of Cell, Developmental and Cancer Biology, Oregon Health & Science University. Portland, OR USA.ORCID 0000-0003-2389-1865 Joe W GrayDepartment of Biomedical Engineering, Oregon Health & Science University. Portland, OR USA.ORCID 0000-0001-9225-6756 Laura M HeiserDepartment of Biomedical Engineering, Oregon Health & Science University. Portland, OR USA.ORCID 0000-0003-3330-0950 Elana J FertigDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0003-3204-342X Johns Hopkins University · USIndiana University Bloomington · USOregon Health & Science University · USCentre de Recherche en Cancérologie de Toulouse · FRGeorgia Institute of Technology · USMemorial Sloan Kettering Cancer Center · US
Funding
WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6MTranslational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI ALAN KEITH MEEKER · 1985 to 2026
$208.6MTumor Antigens for Individual Signatures and TherapyP50CA062924 · NCI · JOHNS HOPKINS UNIVERSITY · PI THOMPSON, ELIZABETH D · 1993 to 2022
$54.6MTransforming Human Pancreatic Cancer Into An Immunologic DiseaseP01CA247886 · NCI · JOHNS HOPKINS UNIVERSITY · PI AZAD, NILOFER S. · 2021 to 2025
$12.7MProject 3: Inhibiting Oxidative Phosphorylation in Pancreatic CancerP50CA221707 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KOPETZ, SCOTT · 2019 to 2023
$11.0MTech Core 2U54CA268083 · NCI · JOHNS HOPKINS UNIVERSITY · PI Pei-Hsun wu · 2022 to 2026
$10.2MTumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic CancerU54CA274371 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Elana Fertig · 2022 to 2026
$9.5MTargeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical TrialR01CA197296 · NCI · JOHNS HOPKINS UNIVERSITY · PI William Reece Burns, Eric Christenson · 2015 to 2026
$5.7MInterrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancerR01CA169702 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ZHENG, LEI · 2013 to 2023
$3.6MT32: Predoctoral and Postdoctoral Training Program in Nanotechnology for Cancer ResearchT32CA153952 · NCI · JOHNS HOPKINS UNIVERSITY · PI Denis Wirtz · 2015 to 2026
$3.5MIntegrating bioinformatics into multiscale models for hepatocellular carcinomaU01CA212007 · NCI · JOHNS HOPKINS UNIVERSITY · PI EWALD, ANDREW JOSEF, FERTIG, ELANA · 2018 to 2022
$3.2MInterrogation of the Impact of Selection on the Evolution of Human PancreaticCancer Precursor LesionsU01CA271273 · NCI · JOHNS HOPKINS UNIVERSITY · PI Elana Fertig, Rachel Karchin · 2022 to 2026
$2.8MNCI NIH HHS 75N91019D00024NCI NIH HHS K08 CA248624NCI NIH HHS P01 CA247886NCI NIH HHS P30 CA006973NCI NIH HHS P50 CA062924NCI NIH HHS P50 CA221707NCI NIH HHS R01 CA169702NCI NIH HHS R01 CA197296NCI NIH HHS T32 CA153952NCI NIH HHS U01 CA212007NCI NIH HHS U01 CA232137NCI NIH HHS U01 CA253403NCI NIH HHS U01 CA271273NCI NIH HHS U24 CA284156NCI NIH HHS U54 CA268083NCI NIH HHS U54 CA274371NIGMS NIH HHS T32 GM148383NINDS NIH HHS K99 NS122085NINDS NIH HHS R00 NS122085
6 · The paper itselfAbstract
Cells are fundamental units of life, constantly interacting and evolving as dynamical systems. While recent spatial multi-omics can quantitate individual cells' characteristics and regulatory programs, forecasting their evolution ultimately requires mathematical modeling. We develop a conceptual framework-a cell behavior hypothesis grammar-that uses natural language statements (cell rules) to create mathematical models. This allows us to systematically integrate biological knowledge and multi-omics data to make them computable. We can then perform virtual "thought experiments" that challenge and extend our understanding of multicellular systems, and ultimately generate new testable hypotheses. In this paper, we motivate and describe the grammar, provide a reference implementation, and demonstrate its potential through a series of examples in tumor biology and immunotherapy. Altogether, this approach provides a bridge between biological, clinical, and systems biology researchers for mathematical modeling of biological systems at scale, allowing the community to extrapolate from single-cell characterization to emergent multicellular behavior.
Identifiers
PMID37745323
PMCPMC10516032
OpenAlexW4386811476
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390